compliance strategy for pharma - terrapinn · compliance strategy for pharma ... effective third...

8
Register now to get the best rate www.healthnetworkcommunications.com/compliance Sponsored by Created by Compliance strategy for pharma 7-8 October 2014 Business Design Centre, London, UK

Upload: doanquynh

Post on 31-Mar-2018

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

Register now to get the best ratewww.healthnetworkcommunications.com/compliance

Sponsored by

Created by

Compliance strategy for pharma

7-8 October 2014Business Design Centre, London, UK

Page 2: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

OUTSOURCING TRACK

VATION KEYNOTES

ROUNDTABLES

EXHIBITION FLOOR

121

As regulatory scrutiny of the pharma industry continues to intensify, compliance teams face increasingly complex challenges related to globalisation, information privacy and security requirements, HCP interaction, and external reporting requirements.

The 2nd annual Pharma Compliance 2014 will provide you with global regulatory updates and case studies from experts with practical experience of successfully optimising their company’s compliance strategies. Learn compliance best-practice with advice on anti-bribery and trust initiatives, marketing and communication strategies, transparent reporting and more. Place your compliance strategy at the forefront of your company’s business planning.

An event to wow

For more information about the event, contact Bernadette Stansfield on+44 (0) 207 608 7057 or email [email protected]

Learn from top industry innovators and influencers

Use our mobile networking app to arrange meetings before and during the event

Explore the latest technology and services

PARTYPARTYPARTYPARTYPARTYPARTY

part

neri

ng

Join elite & exclusive peer to peer roundtable discussions chaired by industry experts

BOOK NOW

Register now to secure your place!Call +44 (0)207 092 1257 or

email [email protected]

Page 3: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

1

2

3

4

5

6

7

8

9

10

Benchmark your compliance programmes against those of Pfizer, Sanofi, AstraZeneca, Novartis and more

Learn the latest disclosure initiatives and implementation strategies across Europe

Gain an understanding of how companies of all sizes are ensuring their compliance programme is adhered to throughout all departments

Optimise your compliance programme and team

Understand how to develop clear monitoring and reporting strategies from the industry’s most successful companies

Share experiences, insights and strategies in interactive peer-to-peer roundtables

Master due diligence and monitoring considerations to ensure robust anti-corruption and anti-bribery programmes

Ensure your interaction with HCPs are fully compliant

Master R&D compliance and transparency in order to minimize risk and increase trust

Network with pioneers, influencers and innovators and return to your company with new ideas and relationships

reasons to attend

Page 4: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

DAY ONE Tuesday 7th October 2014

Peter Herrmann, Corporate Compliance Officer, Actelion Pharmaceuticals

08:00 Registration & morning refreshments

The compliance paradigm change – are we ready? Maria Thestrup, Director Global Integrity and Compliance, Novartis

Opening remarks from the chairDiva Duong, Vice President Compliance EMEA, Cegedim Relationship Management

09:0

0 08

:50

Opening remarks from the chairGreg Maynard, Director, Compliance Solutions for Life Sciences, Health Market Science11

:55

Developing clear and structured monitoring strategies that minimise risks and optimise compliance success ratesDr Marcel Koerting, LL.M., Senior Legal and Compliance Council, Novo Nordisk 10

:00

The EFPIA Disclosure and National Requirements: How to Implement a Global 2 Local (G2L) International IT SystemLaurent Clerc, Regulatory Affairs Expert, BMI SYSTEMFrancis Geysermans, Chief Technology Officer, BMI SYSTEM13

:00

USA Sunshine Act updateKatrin Cahill, Corporate Compliance Associate Director, Biogen Idec16

:00

Taking control of your global compliance ecosystemGreg Maynard, Director, Compliance Solutions for Life Sciences, Health Market Science16

:30

Compliance and financial internal controls – bringing the two worlds togetherAnna Giedrys, Head Business Process Control Global Development, Novartis Pharma AG17

:00

Transparency updateProf. Craig Smith, Director Compliance Leadership Programmes, INSEAD12

:00

10:30 PANEL: How to structure and optimise the role of the compliance officer

09:30 PANEL: How to establish a corporate compliant and ethical culture throughout your company

Dr. Dipti Amin, SVP and Chief Compliance Officer, Quintiles

Marc-Olivier Lamaro, Chief Compliance Officer, Sanofi Pasteur MSD

Ian Storey, Senior Director Compliance, AstraZeneca

12:30 PANEL: Transparency and disclosure initiatives and implementation across Europe

Heather Simmonds, Director, PMCPA

Matthijs Van Blokland, Former Managing Director, Nefarma

Cornelius Erbe, Managing Director, vfa

11:00 Speed networking and morning refreshments

13:30 Lunch

15:30 Refreshment break

17:30 Closing remarks from the chair

17:35 Party

14:30 PEER-TO-PEER ROUNDTABLES

Effectively demonstrating compliance levels are adhered to throughout your organization Sameh Farag, Associate VP Compliance ITC, Global Compliance, Sanofi1

Empowering the compliance role through structured training and developmentFrédéric Poels, Heath Care Compliance Officer, Johnson & Johnson

2Promoting accountability in your organisation to ensure companywide compliancy brand awarenessElizabeth Gwynne, Head Healthcare Compliance, Boehringer Ingelheim

3

Page 5: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

DAY TWO Wednesday 8th October 2014

11:00 Refreshment break

13:30 Lunch

15:40 Afternoon refreshments

17:10 Closing remarks from the chair

Compliance strategies for effective third party risk management Marc-Olivier Lamaro, Chief Compliance Officer, Sanofi Pasteur MSD

Opening remarks from the chairDiva Duong, Vice President Compliance EMEA, Cegedim Relationship Management

09:0

0 08

:50

Effective third party due diligence for pharma companies: understanding current trends and issuesMichael Harris, Head of Integrascreen Sales-EMEA, Governance, Risk and Compliance, Thomson Reuters09

:30

Collaboration between internal audit and compliancePeter Elam, Head of Internal Audit, Novartis10

:00

How to effectively collaborate during an internal audit?Charlotte Tkatch, Regional Director, Ethics and Compliance, North, West EU and Canada, AbbVie10

:30

EFPIA Code UpdateRichard Bergstrom, Director General, EFPIA11

:30

Optimising your interaction with HCPs through a fully compliant and transparent sales strategySir Richard Thompson KCVO, DM, PRCP, President, Royal College of Physicians12

:00

Manage HCP interactions and overcome practical challenges to ensure business process alignment with compliance standards across your organisationGuillaume Roussel, Market Owever, Network, Europe, Veeva Systems12

:30

Optimising R&D compliance and transparency levels in order to improve brand image and increase trustSpeaker to be confirmed14

:30

Case Study: Compliancy in medical devicesChristine Sainvil, Compliance Officer, Eucomed15

:10

Developing clear and structure monitoring strategies that minimize risks and optimize compliance success rates – BI Italy case history Giuseppe Palmieri, Head of Risk & Compliance Management and Audit, Boehringer Ingelheim Italia S.p.A.16

:10

Regional case study: Pharmaceutical compliance in IndiaJason Staples, Senior Counsel, Legal Regulatory and Compliance, Abbott16

:40

CRO perspective of compliance challenges in clinical research and expectations from pharmaDr. Dipti Amin, SVP and Chief Compliance Officer, Quintiles14

:50

Ensuring communication with the public is fully compliant and benefits patientsPaul Woods, Managing Director, Paul Woods Compliance Ltd13

:00

Page 6: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

NetworkingThere’s more to 2014

e know the importance of networking and offer an experience which allows you to do just that. With the bespoke Total Biopharma mobile app, dedicated networking managers and peer-to-

peer partnering, we ensure that you get the most from your time on site. Meet more connections in one place.

DDownload our networking app to get organised and get in touch with all attendees before the event.

Use the Total BioPharma portal to:• Plan your sessions• Build a personalised agenda• Identify exhibitors to visit• Set up onsite meetings with key executives• Network with other attendees

Your networking managerTake advantage of this dedicated and personalised meeting service. Hold meetings with pre-qualified partners arranged by your networking manager in your private on-site meeting room.

Keep all your messages, appointments and favourites at your fingertips and continue networking whilst you’re there. You can still use the networking tool within the app for a full year after the event so you can follow up with anybody you’ve missed months down the line.Rachel Arthurson

WW e know the importance of networking and

offer an experience which allows you to do just that. With the bespoke Total Biopharma

mobile app, dedicated networking managers and peer-to-peer partnering, we ensure that you get the most from your time on site.

Take advantage of this dedicated and personalised meeting service. Hold meetings with pre-qualified partners arranged by your networking manager in your private on-site meeting room.Keep all your messages, appointments and favourites at your fingertips and continue networking whilst you’re there. You can still use the networking tool within the app for a full year after the event so you can follow up with anybody you’ve missed months down the line.Bianca Geldenhuys

Your networking manager

Download our networking app

Use the Total BioPharma portal to:

Page 7: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

Sponsor now

Your opportunity

• Make sales• Debut new products, services and

technologies• Profile your brand• Meet new business partners and suppliers• Develop key relationships

Who you will meet• Compliance• Ethics• Legal Affairs• General Counsel• Regulatory Affairs• Corruption and Risk Management• Corporate Responsibility• Head of Governance• Commercial Operations/Marketing• Medical Director

Why sponsor?• Have pre-arranged 1-2-1 business meetings

with leading companies in pharma and biotech• Educate the compliance community on your

latest products• Showcase thought leadership and expertise • Build brand awareness and company profile• Generate new business leads• Promote new services to key customers

Who should sponsor• Consultants• Enterprise software• Lawyers• Pharma Meeting Planners

For more information about sponsorship and promotional opportunities, contact Edmond Rama on +44 (0) 207 608 7052 or email [email protected]

The 2nd annual Pharma Compliance Europe event is the world’s leading strategic compliance conference for the pharma community, bringing you potential clients that are eager to discover the latest solutions and services in

the market. This is where the pharma community learn from industry thought leaders who will discuss the challenges and best practices in managing risk. If you are in the business of providing world-class solutions, you need to be here.

Sponsors & Exhibitors

Transforming Compliancefor the Life Sciences Industry

Page 8: Compliance strategy for pharma - Terrapinn · Compliance strategy for pharma ... Effective third party due diligence for pharma companies: ... 207 608 7052 or email erama@healthnetworkcommunications.com

Booking code

Reserve your place today

The earlier you book the more you’ll save.

It’s really easy to register online.

And our online calculator will ensure you take advantage of the best deal.

Go to and register www.healthnetworkcommunications.com/compliance

BRING YOUR TEAM

There’s so much great content, you can’t possibly cover it all alone! Bring your team and get an extra discount.

There are special group packages available call +44 (0)207 092 1257

for more details or go to www.healthnetworkcommunications.com/compliance

BOOK NOW

Go to www.healthnetworkcommunications.

com/compliance and register with promo code BR01

Or call +44 (0)207 092 1257

Register now and get the offer price - on your phone

Scan this QR pattern with the camera on your smartphone and register with a promo code BR01 at the special offer price.

Don’t have a QR reader app? You can download one for free from App Store. Don’t have a smartphone? You can also register and get the offer on our website www.healthnetworkcommunications.com/compliance

Package

2 day conference

Before 19th September

£1295 + VAT Save £200

FULL PRICE

£1495 + VAT

BR04

VAT is charged at the current rate and is subject to VAT legislative changes. All bookings will be invoiced at the rate applicable when the booking is made.